According to the source, the claim that New York-based Valthos is developing AI systems to identify and counter biological threats cannot be used for trading analysis without a verifiable primary source such as an official company press release, regulatory filing, or a direct statement from the investing entity. Please provide an official announcement from Valthos or a non-crypto media primary source so we can assess potential impacts on AI-related equities and crypto AI tokens with proper citation.